In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.

Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

BETHLEHEM, Pa. – The Bethlehem Area Board of School Directors is considering the future of cell phone use in the district. During the board's curriculum committee meeting, members discussed the ...

Toll-like receptor 2 (TLR2) and TLR4 are pattern-recognition molecules with an important role in the early innate immune response to microbial challenge, but their presence on mast cells remains ...

Instituto de Investigaciones Biológicas, Universidad Nacional de Mar del Plata (UNMdP)-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Mar del Plata, Argentina Over the past two ...

The rat administration dose was calculated based on the equivalent dose ratio of the human and rat body surface areas ... to identify the expression level of the target gene TLR9, and the cells with ...

Department of Molecular and Environmental Biotechnology, Faculty of Biology and Biotechnology, University of Science, Ho Chi Minh City 700000, Vietnam Vietnam National University, Ho Chi Minh City ...

Center for Renewable Energy and Storage Technologies (CREST), Division of Physical Sciences and Engineering, King Abdullah University of Science and Technology, Thuwal 23955-6900, Kingdom of Saudi ...